The rapid addition of small interfering RNA therapy to usual care after a recent ACS helps more patients achieve recommended ...

Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

Three Motley Fool contributors believe they've found no-brainer healthcare stocks to buy in June. (Amgen): One of the best ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. Here's why this $150 billion pharmaceutical powerhouse deserves a ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co., GE Aerospace and ...

Federal jurors in Delaware found that Amgen violated antitrust laws by bundling its cholesterol treatment with substantial ...

A seminal decision concerning second medical use patents and questions over confidentiality were among the top talking points ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.